Geode Capital Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Buy
697,321
+42,021
+6% +$89.6K ﹤0.01% 3118
2025
Q4
$1.06M Sell
655,300
-2,221
-0.3% -$3.49K ﹤0.01% 3362
2025
Q3
$1.11M Sell
657,521
-26,017
-4% -$42.1K ﹤0.01% 3357
2025
Q2
$827K Sell
683,538
-772,650
-53% -$1.12M ﹤0.01% 3390
2025
Q1
$1.85M Buy
1,456,188
+22,971
+2% +$60K ﹤0.01% 3064
2024
Q4
$4.66M Buy
1,433,217
+26,341
+2% +$94.9K ﹤0.01% 2778
2024
Q3
$4.63M Sell
1,406,876
-8,363
-0.6% -$32.6K ﹤0.01% 2794
2024
Q2
$6.02M Sell
1,415,239
-16,774
-1% -$163K ﹤0.01% 2623
2024
Q1
$21.1M Buy
1,432,013
+27,945
+2% +$422K ﹤0.01% 1893
2023
Q4
$13.5M Buy
1,404,068
+84,068
+6% +$581K ﹤0.01% 2154
2023
Q3
$6.15M Buy
1,320,000
+117,984
+10% +$587K ﹤0.01% 2530
2023
Q2
$6.43M Buy
1,202,016
+38,320
+3% +$236K ﹤0.01% 2558
2023
Q1
$8.34M Buy
1,163,696
+34,353
+3% +$207K ﹤0.01% 2372
2022
Q4
$7.58M Buy
1,129,343
+80,830
+8% +$443K ﹤0.01% 2440
2022
Q3
$3.63M Buy
1,048,513
+23,242
+2% +$88.9K ﹤0.01% 2844
2022
Q2
$3.02M Buy
1,025,271
+35,732
+4% +$188K ﹤0.01% 2965
2022
Q1
$8.72M Sell
989,539
-29,222
-3% -$323K ﹤0.01% 2444
2021
Q4
$16.4M Sell
1,018,761
-23,244
-2% -$437K ﹤0.01% 2093
2021
Q3
$21.8M Sell
1,042,005
-4,746
-0.5% -$114K ﹤0.01% 1896
2021
Q2
$28.1M Buy
1,046,751
+99,700
+11% +$2.92M ﹤0.01% 1736
2021
Q1
$30.2M Buy
947,051
+62,382
+7% +$1.51M ﹤0.01% 1602
2020
Q4
$20.2M Buy
884,669
+99,300
+13% +$2.29M ﹤0.01% 1708
2020
Q3
$19.8M Buy
785,369
+39,763
+5% +$1.09M ﹤0.01% 1538
2020
Q2
$20.8M Buy
745,606
+2,088
+0.3% +$36.3K ﹤0.01% 1479
2020
Q1
$4.33M Buy
743,518
+52,516
+8% +$477K ﹤0.01% 2230
2019
Q4
$7.52M Buy
691,002
+77,809
+13% +$770K ﹤0.01% 2208
2019
Q3
$7.82M Buy
613,193
+15,064
+3% +$217K ﹤0.01% 2090
2019
Q2
$10.2M Buy
598,129
+90,465
+18% +$1.55M ﹤0.01% 1945
2019
Q1
$9.13M Buy
507,664
+51,790
+11% +$895K ﹤0.01% 1954
2018
Q4
$5.79M Buy
455,874
+39,246
+9% +$658K ﹤0.01% 2128
2018
Q3
$8.93M Buy
416,628
+39,526
+10% +$843K ﹤0.01% 2010
2018
Q2
$7.79M Buy
377,102
+63,242
+20% +$1.42M ﹤0.01% 2063
2018
Q1
$7.9M Buy
313,860
+15,701
+5% +$381K ﹤0.01% 1933
2017
Q4
$5.67M Buy
298,159
+2,472
+0.8% +$46.1K ﹤0.01% 2140
2017
Q3
$5.46M Buy
295,687
+10,715
+4% +$186K ﹤0.01% 2148
2017
Q2
$4.99M Buy
284,972
+24,302
+9% +$464K ﹤0.01% 2145
2017
Q1
$4.85M Buy
260,670
+10,983
+4% +$212K ﹤0.01% 2138
2016
Q4
$5.1M Buy
249,687
+24,546
+11% +$618K ﹤0.01% 2049
2016
Q3
$6.73M Buy
225,141
+3,155
+1% +$93.8K ﹤0.01% 1762
2016
Q2
$5.99M Buy
221,986
+18,482
+9% +$417K ﹤0.01% 1791
2016
Q1
$3.81K Buy
203,504
+3,634
+2% +$69.2K ﹤0.01% 2046
2015
Q4
$6.19M Buy
199,870
+12,228
+7% +$371K ﹤0.01% 1719
2015
Q3
$4.02M Buy
187,642
+19,705
+12% +$618K ﹤0.01% 1977
2015
Q2
$6.38M Buy
167,937
+29,555
+21% +$971K ﹤0.01% 1739
2015
Q1
$4.34M Buy
138,382
+74,232
+116% +$2.52M ﹤0.01% 1941
2014
Q4
$2.25M Buy
64,150
+2,613
+4% +$65.1K ﹤0.01% 2353
2014
Q3
$1.29M Buy
61,537
+1,230
+2% +$25.4K ﹤0.01% 2632
2014
Q2
$1.31M Buy
60,307
+9,891
+20% +$208K ﹤0.01% 2632
2014
Q1
$1.4M Buy
50,416
+18,487
+58% +$653K ﹤0.01% 2567
2013
Q4
$875K Buy
+31,929
New +$835K ﹤0.01% 2798

Other funds holding MGNX

Geode Capital Management's MGNX Position: Q1 2026 in Review

Geode Capital Management increased its MacroGenics (MGNX) stake by 6.4% in Q1 2026, buying an estimated $89.6K and bringing the position to 697,321 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3118.

Geode Capital Management first reported a position in MGNX in Q4 2013 and has held it in 50 quarters since. The position peaked at $30.2M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Geode Capital Management held 697,321 shares of MacroGenics worth $2.02M as of Q1 2026.
  • Geode Capital Management bought 42,021 MacroGenics shares in Q1 2026, an estimated $89.6K.
  • MacroGenics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3118 holding.
  • Geode Capital Management first reported a position in MacroGenics in Q4 2013 and has held it in 50 quarters since.
  • Geode Capital Management's MacroGenics position peaked at $30.2M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.